Talecris Biotherapeutics Inc entered the industry of Biotherapeutics in 2007 and has grown to employ 1 to 4 people, generating an annual revenue of $100.000 to $499.999. The NAICS classifies this business under the code 424210, which describes it as a Biotherapeutics. For further clarification, the SIC classifies this business under the code 5122 and described it as a Biotherapeutics. The business provides service to the BOTH market.
To acquire more information, please contact Gisela Fleming by calling (919) 508-8728 during business hours. You can also write to the business’ Single Location at 1017 Main Campus Drive # 1200, Raleigh, North Carolina NC 27606. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .
| Company: | Talecris Biotherapeutics Inc |
| Representative: | Gisela Fleming |
| Place of Business: | 1017 Main Campus Drive # 1200, Raleigh, NC 27606 |
| Contact Number: | (919) 508-8728 |
| Type of Service: | Biotherapeutics |
| SIC Number: | 5122 |
| NAICS Number: | 424210 |
| Locality: | Single Location |
| Market Type: | B2B & B2C |
| Began: | 2007 |
| Income/Year: | $100.000 to $499.999 |
| Laborers: | 1 to 4 |
| Share This Company: |
Talecris Biotherapeutics Inc is a company operating from Wake, North Carolina providing professional Biotherapeutics and relevant BOTH variables. It was founded in 2007 and registered with the SIC code 5122 as Biotherapeutics, and with the NAICS code 424210 as Biotherapeutics.
With a current employee count of 1 to 4, Talecris Biotherapeutics Inc has gone to report making $100.000 to $499.999 per annum on its journey towards growth. This company invites you to contact its representative Gisela Fleming at (919) 508-8728 for related queries, or to locate its Single Location using the coordinates 35.769985,-78.677697.
The Single Location can also be found at the street address 1017 Main Campus Drive # 1200 in Raleigh, North Carolina 27606 and can be engaged online through the company website at , the company Twitter , and Facebook page .